Page Title or Custom page title

Q3 highlights on our users’ published publications include: the world’s 1st QPatch Compact paper from Bruce Bean’s lab, at Harvard; four papers using machine learning in drug discovery and hERG block prediction; and two papers on MDR pathogen targeting compounds. Read the full list here!

Using automated patch clamp assays, we gain insights into altered ion channel densities, current dynamics, and neuron excitability in disease neurons, with the potential to open doors on new therapeutic targets and drug discovery. Learn more and read our new application report here.

Harvard researchers from Bruce Bean’s lab explain how VX-150 and VX-548 target Nav1.8 ion channels for potential pain relief. This breakthrough highlights the role of automated patching in advancing our understanding of pain. Read more here.

The use of primary hippocampal neurons allows for insights that are crucial for developing more effective treatments for cognitive impairment, psychosis, and schizophrenia. Learn more and read our new application report here.